GR3006182T3 - Synergistic combination of decarboxylase inhibitors and L-dopa pellets - Google Patents

Synergistic combination of decarboxylase inhibitors and L-dopa pellets

Info

Publication number
GR3006182T3
GR3006182T3 GR920402503T GR920402503T GR3006182T3 GR 3006182 T3 GR3006182 T3 GR 3006182T3 GR 920402503 T GR920402503 T GR 920402503T GR 920402503 T GR920402503 T GR 920402503T GR 3006182 T3 GR3006182 T3 GR 3006182T3
Authority
GR
Greece
Prior art keywords
synergistic combination
decarboxylase inhibitors
dopa
pellets
dopa pellets
Prior art date
Application number
GR920402503T
Other languages
English (en)
Inventor
Manfred Dr Albring
Helmut Dr Hettche
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6343914&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3006182(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of GR3006182T3 publication Critical patent/GR3006182T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Lock And Its Accessories (AREA)
GR920402503T 1987-12-31 1992-11-05 Synergistic combination of decarboxylase inhibitors and L-dopa pellets GR3006182T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3744646 1987-12-31

Publications (1)

Publication Number Publication Date
GR3006182T3 true GR3006182T3 (en) 1993-06-21

Family

ID=6343914

Family Applications (2)

Application Number Title Priority Date Filing Date
GR920402503T GR3006182T3 (en) 1987-12-31 1992-11-05 Synergistic combination of decarboxylase inhibitors and L-dopa pellets
GR970402622T GR3024980T3 (en) 1987-12-31 1997-10-09 Synergistic combination of decarboxylase inhibitors and L-dopa pellets

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR970402622T GR3024980T3 (en) 1987-12-31 1997-10-09 Synergistic combination of decarboxylase inhibitors and L-dopa pellets

Country Status (13)

Country Link
EP (1) EP0324947B2 (el)
JP (1) JPH0296520A (el)
AT (1) ATE81971T1 (el)
AU (1) AU611512B2 (el)
CA (1) CA1315690C (el)
DE (1) DE3875716D1 (el)
DK (1) DK730488A (el)
ES (1) ES2052681T5 (el)
FI (1) FI886047A (el)
GR (2) GR3006182T3 (el)
IE (1) IE62643B1 (el)
NO (1) NO885820L (el)
PT (1) PT89350B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
DE4101873C2 (de) 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
US8815950B2 (en) 2003-08-29 2014-08-26 Janssen Biotech, Inc. Pharmaceutical compositions and method of using levodopa and carbidopa
EP2508174A1 (en) * 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3769424A (en) * 1970-10-01 1973-10-30 Merck & Co Inc Composition and method of treating dopamine deficiency in brain tissue
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.

Also Published As

Publication number Publication date
ES2052681T5 (es) 1997-12-01
EP0324947B1 (de) 1992-11-04
ES2052681T3 (es) 1994-07-16
ATE81971T1 (de) 1992-11-15
DK730488D0 (da) 1988-12-30
PT89350A (pt) 1989-12-29
FI886047A (fi) 1989-07-01
GR3024980T3 (en) 1998-01-30
NO885820D0 (no) 1988-12-30
EP0324947A1 (de) 1989-07-26
AU611512B2 (en) 1991-06-13
AU2758288A (en) 1989-07-06
DE3875716D1 (de) 1992-12-10
EP0324947B2 (de) 1997-08-20
DK730488A (da) 1989-07-01
PT89350B (pt) 1993-09-30
IE883894L (en) 1989-06-30
IE62643B1 (en) 1995-02-22
CA1315690C (en) 1993-04-06
JPH0296520A (ja) 1990-04-09
NO885820L (no) 1989-07-03

Similar Documents

Publication Publication Date Title
BG47341A3 (en) Means for regulating plant growth
ZA907338B (en) Thienylcarboxylates of amino alcohols
HUT43952A (en) Process for preparing pharmaceuticals comprising (-)-3-(3,4-dihydroxyphenyl)-l-alanine-methylester
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
HK74697A (en) Pharmaceutical therapeutic use of glutathione derivatives
IL87566A0 (en) Medical composition for the treatment of diabetes comprising a benzamide derivative
GR3024980T3 (en) Synergistic combination of decarboxylase inhibitors and L-dopa pellets
AU3228489A (en) Treatment of equine livestock
GR3007995T3 (el)
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
EP0303251A3 (en) Modified tpa-containing injection composition
GR3001277T3 (en) Chlorpheniramine therapy
EP0441106A3 (en) Thyroxine in restoring neuronal plasticity
GR900300082T1 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
NZ220242A (en) Regulating fertility in cattle by administering epostane
EP0166056A3 (en) Pharmaceutical dosage unit
IL92438A0 (en) Amine salts of 1,4,2-oxazaphospholidine-4-acetic acid,2-alkoxy-2-oxides and herbicidal compositions
PH22450A (en) Agent for treating parkinson's disease or parkinsonism
ZA86828B (en) Agent for treating parkinson's disease or parkinsonism
CS233887A1 (en) Sposob cistenia odpadnych vod vznikajucich pri vyrobe 4 amino difenylaminu